Antidiazox Oral Suspension

Recommended Dosage And Important Administration Instructions

Important Administration Instructions For Pediatric Patients 11 Years Of Age Or Younger

Directions For Mixing Antidiazox For Oral Suspension

• Measure 48 mL of water for preparation of the 100 mg/5 mL suspension
• Tap bottle until all powder flows freely.
• Add approximately one-half of the 48 mL of water required for reconstitution and shake vigorously to suspend powder.
• Add remainder of water and again shake vigorously

• Megaloblastic Anemia
• Folic Acid Deficiency
• Vitamin/Mineral Supplementation
• Vitamin/Mineral Supplementation during Pregnancy/Lactation

• The tablets should be swallowed with a drink of water.
• The doctor/pharmacist will decide what dose of tablets you need to take. The dose will be on the pharmacist’s label. Check with your doctor or pharmacist if you are not sure. Carry on taking them for as long as you have been told unless you have any problem. In that case, check with your doctor/pharmacist.
• The recommended dose for adults, the elderly and children over 1 year is 1 tablet daily for up to 4 months. After that your doctor may reduce the dose to 1 tablet every few days. In rare cases some people may need to take up to 3 tablets daily.

• nausea, loss of appetite;
• bloating, gas;
• bitter or unpleasant taste in your mouth;
• sleep problems;
• depression; or
• feeling excited or irritable.

• For the treatment of folate-deficient megaloblastic anaemia due to malnutrition, malabsorption syndromes (such as coeliac disease or sprue) and increased utilisation as in pregnancy. It should not be used alone in undiagnosed megaloblastic anaemia including in infancy, pernicious anaemia or macrocytic anaemia of unknown aetiology, unless administered with adequate amounts of hydroxocobalamin.
• For the prophylaxis of drug induced folate deficiency e.g., caused by administration of phenytoin, phenobarbital and primidone. (See section 4.5).
• For the prophylaxis against folate deficiency in chronic haemolytic states or in renal dialysis.
• For the prevention of neural tube defects for woman planning a pregnancy and known to be at risk

• Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
• Long-term folate therapy is contraindicated in any patient with untreated cobalamin deficiency. This can be untreated pernicious anaemia or other cause of cobalamin deficiency, including lifelong vegetarians. In elderly people, a cobalamin absorption test should be done before long-term folate therapy. Folate given to such patients for 3 months or longer has precipitated cobalamin neuropathy. No harm results from short courses of folate
• Folic acid should never be given alone in the treatment of Addisonian pernicious anaemia and other vitamin B₁₂deficiency states because it may precipitate the onset of subacute combined degeneration of the spinal cord
• Folic acid should not be used in malignant disease unless megaloblastic anaemia owing to folate deficiency is an important complication.

• Patients with vitamin B₁₂deficiency should not be treated with folic acid unless administered with adequate amounts of hydroxocobalamin, as it can mask the condition but the subacute irreversible damage to the nervous system will continue. The deficiency can be due to undiagnosed megaloblastic anaemia including in infancy, pernicious anaemia or macrocytic anaemia of unknown aethiology or other cause of cobalamin deficiency, including lifelong vegetarians.
• Caution should be exercised when administering folic acid to patients who may have folate dependent tumours.
• This product is not intended for healthy pregnant women where lower doses are recommended, but for pregnant women with folic acid deficiency or women at risk for the reoccurrence of neural tube defects.
• This product contains lactose monohydrate. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose – galactose malabsorption should not take this medicine

• Glucosamine Sulfate (Potassium Salt): 667 mg
• Equiv to Glucosamine Sulfate: 500 mg
• Chondroitin Sulfate: 400 mg

• Gas
• Bloating
• Cramps
• Bleeding disorder
• Hair loss
• Hives
• Rash
• Skin irritation
• Sun sensitivity
• Nausea

• • Do not drive or operate machinery
  • Pregnant or breastfeeding
  • Pregnant, planning to become pregnant or breastfeeding

• • • Antimitotic chemotherapy
    • Aspirin
    • Clopidogrel
    • Naproxen
    • Warfarin

• • • • Children
      • Hypersensitivity

• • • • • Do not use more than the prescribed dose. Taking more medication will not improve your symptoms; rather they may cause poisoning or serious side-effects. If you suspect that you or anyone else who may have overdosed of Osteomin Tablet, please go to the emergency department of the closest hospital or nursing home. Bring a medicine box, container, or label with you to help doctors with the necessary information.
        • Do not give your medicines to other people even if you know that they have the same condition or it seems that they may have similar conditions. This may lead to overdosage.
        • Please consult your physician or pharmacist or product package for more information.

• • • • • Store medicines at room temperature, away from heat and direct light. Do not freeze medicines unless required by package insert. Keep medicines away from children and pets.
        • Do not flush medications down the toilet or pour them into drainage unless instructed to do so. Medication discarded in this manner may contaminate the environment. Please consult your pharmacist or doctor for more details on how to safely discard Osteomin Tablet.